Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
Clinical trial NCT05882630 · UNKNOWN
Trial details
- NCT number
- NCT05882630
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.